CapsuleAnti Cancer
Imatinib Mesylate · Tyrosine kinase inhibitor
Imatinib Mesylate is a tyrosine kinase inhibitor supplied as capsules. It is used in standard clinical practice for chronic myeloid leukaemia and gastrointestinal stromal tumours, as described in general pharmacological references.
Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.
01Specification